跳至主要内容
临床试验/CTRI/2024/02/062227
CTRI/2024/02/062227招募中4 期

evetiracetam versus phenytoin as second-line anti-seizure medication in neonates: A randomized controlled trial - NI

All India Institute of Medical Sciences, Rishikesh0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Term neonates (up to first 28 days of life) and late preterm neonates (up to 44 weeks postmenstrual age) with persistent seizures despite the administration of phenobarbitone as the first-line anti-seizure medication

排除标准

  • Seizures secondary to correctable metabolic causes like hypoglycemia, hypocalcemia
  • Neonates with major congenital malformations
  • Non-availability of parental consent

研究者

相似试验